tiprankstipranks
Trending News
More News >
STRATEC Biomedical (GB:0RAR)
:0RAR
UK Market

STRATEC Biomedical (0RAR) Stock News & Sentiment

Compare
1 Followers
STRATEC Biomedical (0RAR) Unveils Dividend Details for Q3: Mark Your Calendar!
Premium
Dividends
STRATEC Biomedical (0RAR) Unveils Dividend Details for Q3: Mark Your Calendar!
30d ago
STRATEC Biomedical (LSE: 0RAR) has declared, under its dividend policy, a yearly cash dividend in the amount of €0.60 per common share. The dividend will be payable on 07/02/2025, to ...Read more
0RAR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0RAR Earnings this Week: How Will it Perform?
8M ago
German Market Update: Three Shares to Buy Today
Premium
Global Markets
German Market Update: Three Shares to Buy Today
2y ago

News Score - Last 7 Days

Neutral
GB:0RAR
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week99%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0RAR’s Media Buzz Sentiment?
1 articles about GB:0RAR were published this week. In an average week, 1 articles are published.
    What is GB:0RAR’s weekly average amount of articles?
    In an average week, 1 articles about GB:0RAR are published.
      What is GB:0RAR’s News Sentiment?
      99% of articles about GB:0RAR were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        USNAUSANA Health
        OGNOrganon
        ENSGThe Ensign Group
        ABTAbbott Laboratories
        SHGSingular Health Group Ltd
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis